1. Home
  2. NTRA vs MT Comparison

NTRA vs MT Comparison

Compare NTRA & MT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$400.92

Market Cap

47.4B

Sector

Health Care

ML Signal

N/A

Logo Arcelor Mittal NY Registry Shares NEW

MT

Arcelor Mittal NY Registry Shares NEW

N/A

Current Price

$64.09

Market Cap

47.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
MT
Founded
2003
1976
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Medical Specialities
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
47.4B
47.8B
IPO Year
2015
2003

Fundamental Metrics

Financial Performance
Metric
NTRA
MT
Price
$400.92
$64.09
Analyst Decision
Strong Buy
Buy
Analyst Count
23
8
Target Price
★ $383.66
$77.80
AVG Volume (30 Days)
★ 1.7M
1.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 0.83%
EPS Growth
★ 0.65
N/A
EPS
N/A
★ N/A
Revenue
★ $210,939,000.00
N/A
Revenue This Year
$26.17
$9.64
Revenue Next Year
$20.65
$8.30
P/E Ratio
★ N/A
$15.95
Revenue Growth
N/A
★ N/A
52 Week Low
$169.50
$36.70
52 Week High
$437.41
$79.68

Technical Indicators

Market Signals
Indicator
NTRA
MT
Relative Strength Index (RSI) 61.52 36.08
Support Level $187.64 $59.04
Resistance Level N/A $64.18
Average True Range (ATR) 17.33 1.27
MACD -3.35 -0.76
Stochastic Oscillator 50.04 27.15

Price Performance

Historical Comparison
NTRA
MT

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About MT Arcelor Mittal NY Registry Shares NEW

ArcelorMittal SA is an integrated steel and mining company. The company's reportable operating segments include North America, Brazil, Europe, India and JVs, Sustainable Solutions, and Mining. It generates maximum revenue from the Europe segment. The Europe segment produces hot-rolled coil, cold-rolled coil, coated products, tinplate, plate, and slab. These products are sold to customers in the automotive, general, and packaging sectors, as well as producing long products consisting of sections, wire rods, rebar, billets, blooms and wire drawing, and tubular products. Geographically, it derives a majority of its revenue from the United States, followed by Brazil, Canada, Mexico, Argentina, and other markets.

Share on Social Networks: